eftriaxone & Tazobactam Injection 1.5 g Supplier for Cape Town, South Africa
Advanced Antibiotic Injection Manufactured in India
Ernest Oncology provides Ceftriaxone & Tazobactam Injection 1.5 g, a sterile injectable antibiotic formulated with Ceftriaxone, a third-generation cephalosporin antibiotic, and Tazobactam, a beta-lactamase inhibitor. Produced in WHO-GMP certified pharmaceutical facilities in India, the medicine is manufactured using advanced sterile technology and rigorous quality standards to ensure consistent purity, safety, and effectiveness.
The injection is designed for intravenous (IV) and intramuscular (IM) administration under the supervision of qualified healthcare professionals.
Cape Town Pharmaceutical Market Information
Cape Town is one of South Africa's leading healthcare destinations, supported by modern hospitals, specialist medical centres, and an expanding pharmaceutical sector. Healthcare providers continue to seek high-quality injectable medicines that meet internationally recognized manufacturing and quality standards.
Indian pharmaceutical manufacturers are globally respected for producing reliable medicines using advanced technology, stringent quality systems, and internationally accepted manufacturing practices.
Why Choose Indian Pharmaceutical Exports
India continues to be a preferred global source for pharmaceutical products because of its manufacturing expertise and commitment to quality.
Benefits of Indian Pharmaceutical Manufacturing
- WHO-GMP certified manufacturing plants
- International pharmaceutical quality standards
- Advanced sterile production facilities
- High-quality pharmaceutical ingredients
- Reliable manufacturing consistency
- Modern quality control systems
- Export-standard packaging
- Continuous quality monitoring
- Strong global healthcare reputation
- Innovation-driven pharmaceutical production
Product Overview
| Product Details | Information |
|---|---|
| Product Name | Ceftriaxone & Tazobactam Injection |
| Strength | 1.5 g |
| Active Ingredients | Ceftriaxone + Tazobactam |
| Dosage Form | Sterile Powder for Injection |
| Route of Administration | IM / IV |
| Therapeutic Category | Broad-Spectrum Antibiotic |
| Packaging | Sterile Export Packaging |
| Country of Origin | India |
Key Features
- Dual-action antibiotic formulation
- Ceftriaxone and Tazobactam combination
- Broad-spectrum antibacterial activity
- Sterile injectable preparation
- WHO-GMP certified manufacturing
- High pharmaceutical purity
- Stable formulation
- Batch-tested quality
- Export-quality packaging
- Manufactured according to international standards
Mechanism of Action
This combination provides antibacterial activity through two complementary mechanisms.
- Ceftriaxone interferes with bacterial cell wall synthesis, leading to bacterial cell death.
- Tazobactam inhibits beta-lactamase enzymes that may reduce antibiotic activity, helping preserve the effectiveness of Ceftriaxone.
Together, they enhance antibacterial coverage against susceptible microorganisms.
Product Description
Ceftriaxone & Tazobactam Injection 1.5 g is a sterile injectable antibiotic that combines the antibacterial action of Ceftriaxone with the enzyme-inhibiting activity of Tazobactam. The combination is formulated to help improve antibacterial effectiveness against susceptible bacterial infections by protecting the antibiotic from beta-lactamase enzymes produced by certain bacteria.
The medicine is intended for administration by qualified healthcare professionals through intramuscular (IM) or intravenous (IV) injection.
